The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

SPIRIVA 18 microgram, inhalation powder, hard capsule

18 microgram(s) Inhalation powder, hard capsule

Boehringer Ingelheim International GmbHPA0775/002/001

Main Information

Trade NameSPIRIVA 18 microgram, inhalation powder, hard capsule
Active SubstancesTiotropium
Strength18 microgram(s)
Dosage FormInhalation powder, hard capsule
Licence HolderBoehringer Ingelheim International GmbH
Licence NumberPA0775/002/001

Group Information

ATC CodeR03BB Anticholinergics
R03BB04 tiotropium bromide


Licence Issued28/06/2002
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceNone
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back